Addressing the growing problem of hypertension in africa in collaboration with the faith based...

Healthy Heart Africa: Addressing the Growing Problem of Hypertension in Africa in collaboration with the Faith-Based Sector

23 February 2015

AstraZeneca Vice President, Healthy Heart Africa

Samer Al-Hallaq

2

AstraZeneca: who are we

50.000

employees in 100

countries

Supply &

Manufacturing in

16 countries

R&D capabilities

across 3 continents

A 100-year heritage

in cardiovascular

disease

Why are we here today?

• Kioko has high blood pressure but is completely unaware

• Has a wife and two children and lives outside Nairobi

• Earns approx. $300 per month, and has few savings

• Doesn’t believe in exercise… he thinks its for the very rich or

poor… and admits that he’s slightly overweight.

• Eats two big meals a day, smokes and drinks beer socially

• Doesn’t engage with healthcare system very often and has

never been told about hypertension

Meet Kioko

3

Cardiovascular Disease in Africa

Around 40% of adult Kenyans have raised blood pressure

Source: World Health Organization

Tackling the challenges of hypertension

Healthy Heart Africa

5

• Healthy Heart Africa is an innovative and sustainable programme

that aims to improve the lives of hypertensive patients across Africa

• The first initiative of this scale will lay the foundation for future programmes

focused on preventing and treating NCDs

• In line with the World Health Organisation (WHO)’s ‘25 by 2025’ framework

for preventing and controlling NCDs

• The ambition of Healthy Heart Africa is to reach 10 million hypertensive

patients across Africa by 2025.

Healthy Heart Africa A partnership approach

6


A holistic approach to healthcare delivery

7

Ba

rrie

rs

Education & Awareness

Provider training & Guidelines Access & Affordability

So

luti

on

s

Mobilise patients to seek

screening and treatment

Promote routine screening

and timely diagnosis

Improve access and

adherence to treatment

Ou

tco

me

s

1. Increased awareness of risks of hypertension

2. Increased motivation to be diagnosed and seek the right treatment

3. Increased access to appropriate and affordable medicine


The ten year plan

• Kenya programme roll-out

• Build alliances with key stakeholders

• Establish thought leadership platform

• Evaluate preliminary results and

refine programme components

• Extend scope in Kenya, and expand

across East Africa, Nigeria

• Review, evaluate and report on

programme impact

• Solidify our global leadership

reputation

• Ensure programme sustainability with

Global Public Health partners

FBOs are central to Healthy Heart Africa’s strategy

9

Your reach to low- and middle-income patients

Your scale and presence across the continent

Your know-how and experience


A real and lasting impact

10

11

Samer Al-Hallaq AstraZeneca Vice President, Healthy Heart Africa

Thanks!

AstraZeneca Pharmaceuticals (Pty) Ltd. Reg. No. 1992/005854/07. Building 2, Northdowns Offi ce Park, 17 Georgian Crescent West,

Bryanston, South Africa, 2191. Private Bag X23, Bryanston, South Africa, 2021. Tel: +27 (0) 11 797-6000. Fax: +27 (0) 11 797-6001.

www.astrazeneca.com. Expiry Date: February 2016. Log number: SSA COR 02/15/005

Addressing the growing problem of hypertension in africa in collaboration with the faith based...

Documents

Transcript of Addressing the growing problem of hypertension in africa in collaboration with the faith based...